NeuroVive Pharmaceutical AB Bennfentes tulajdonlás
Mi az NeuroVive Pharmaceutical AB Bennfentes tulajdonlás?
A Bennfentes tulajdonlás az NeuroVive Pharmaceutical AB - 4.31%
Mi a Bennfentes tulajdonlás meghatározása?
A bennfentes tulajdonjog kiszámítása a bennfentesek tulajdonában lévő részvények (részvényesek, akik a vállalat több mint 5% -át, vagy a vállalat tisztségviselőjét vagy igazgatóját birtokolják) teljes létszámával, osztva a teljes részvénykivonással.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Bennfentes tulajdonlás a Health Care szektor a OTC-on cégekben a NeuroVive Pharmaceutical AB -hoz képest
Mit csinál NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
bennfentes tulajdonlás -hoz hasonló cégek NeuroVive Pharmaceutical AB
- GenMark Diagnostics Inc nak Bennfentes tulajdonlás 4.29% van
- Boingo Wireless Inc nak Bennfentes tulajdonlás 4.30% van
- ACNB nak Bennfentes tulajdonlás 4.30% van
- Westinghouse Air Brake Technologies Corp nak Bennfentes tulajdonlás 4.30% van
- Silvercorp Metals Inc nak Bennfentes tulajdonlás 4.30% van
- Nexstar Media Inc nak Bennfentes tulajdonlás 4.31% van
- NeuroVive Pharmaceutical AB nak Bennfentes tulajdonlás 4.31% van
- Cabaletta Bio Inc nak Bennfentes tulajdonlás 4.31% van
- NZME nak Bennfentes tulajdonlás 4.31% van
- Quadro Resources nak Bennfentes tulajdonlás 4.31% van
- Quadro Resources nak Bennfentes tulajdonlás 4.31% van
- Silvercorp Metals nak Bennfentes tulajdonlás 4.32% van
- Rocket Companies nak Bennfentes tulajdonlás 4.32% van